Billings Clinic
Especially For:

Clinical Trials

Title   E3108: A Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer with Tamoxifen
Description   A Phase II Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen
IRB Number   E3108
Category   Breast Cancer
Inclusion/Notes   Stage III/Locally Advanced or Metastatic (Stage IV) Breast cancer. May have had certain prior therapies prior to cancer becoming metastatic. No prior Tamoxifen.

Multiple specific Inclusion/Exclusion Criteria need to be met to be able to participate in this clinical trial.
Status   Open to Enrollment
Start Date   11/12/2010
Principal Investigator (PI)   Brock Whittenberger, MD
Contact Name   Tauna Jeffery, RN
Contact Email   tjeffery@billingsclinic.org
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.